A citation-based method for searching scientific literature

Hannah Christina Puhr, Matthias Preusser, Gerald Prager, Aysegül Ilhan-Mutlu. Cancers (Basel) 2020
Times Cited: 5







List of co-cited articles
5 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
60

New agents on the horizon in gastric cancer.
F Lordick, K Shitara, Y Y Janjigian. Ann Oncol 2017
59
40

Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges.
Dai Fukumura, Jonas Kloepper, Zohreh Amoozgar, Dan G Duda, Rakesh K Jain. Nat Rev Clin Oncol 2018
748
40

VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2-Study.
Elizabeth Smyth, Maren Knödler, Anne Giraut, Murielle Mauer, Magnus Nilsson, Nicole Van Grieken, Anna Dorothea Wagner, Markus Moehler, Florian Lordick. Front Oncol 2020
30
40

Update on gastric cancer treatments and gene therapies.
Alessio Biagioni, Ileana Skalamera, Sara Peri, Nicola Schiavone, Fabio Cianchi, Elisa Giommoni, Lucia Magnelli, Laura Papucci. Cancer Metastasis Rev 2019
81
40

Metabolic tumor burden on postsurgical PET/CT predicts survival of patients with gastric cancer.
Gaofeng Sun, Chao Cheng, Xiao Li, Tao Wang, Jian Yang, Danni Li. Cancer Imaging 2019
9
20

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.
Shinichi Sakuramoto, Mitsuru Sasako, Toshiharu Yamaguchi, Taira Kinoshita, Masashi Fujii, Atsushi Nashimoto, Hiroshi Furukawa, Toshifusa Nakajima, Yasuo Ohashi, Hiroshi Imamura,[...]. N Engl J Med 2007
20

The challenge of screening for early gastric cancer in China.
Liang Zong, Masanobu Abe, Yasuyuki Seto, Jiafu Ji. Lancet 2016
201
20

Oncology Practice During the COVID-19 Pandemic.
Deborah Schrag, Dawn L Hershman, Ethan Basch. JAMA 2020
170
20

Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer.
Giandomenico Roviello, Andrea Ravelli, Karol Polom, Roberto Petrioli, Luigi Marano, Daniele Marrelli, Franco Roviello, Daniele Generali. Cancer Lett 2016
98
20

Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma.
Ruiping Wang, Minghao Dang, Kazuto Harada, Guangchun Han, Fang Wang, Melissa Pool Pizzi, Meina Zhao, Ghia Tatlonghari, Shaojun Zhang, Dapeng Hao,[...]. Nat Med 2021
56
20

Screening and Early Detection of Gastric Cancer: East Versus West.
Yun-Suhk Suh, Han-Kwang Yang. Surg Clin North Am 2015
44
20


Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology.
Jaffer A Ajani, Thomas A D'Amico, Khaldoun Almhanna, David J Bentrem, Joseph Chao, Prajnan Das, Crystal S Denlinger, Paul Fanta, Farhood Farjah, Charles S Fuchs,[...]. J Natl Compr Canc Netw 2016
589
20

Apatinib combined with oral etoposide in patients with platinum-resistant or platinum-refractory ovarian cancer (AEROC): a phase 2, single-arm, prospective study.
Chun-Yan Lan, Yin Wang, Ying Xiong, Jun-Dong Li, Jing-Xian Shen, Yan-Fang Li, Min Zheng, Yan-Na Zhang, Yan-Ling Feng, Qing Liu,[...]. Lancet Oncol 2018
103
20

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial.
Hansjochen Wilke, Kei Muro, Eric Van Cutsem, Sang-Cheul Oh, György Bodoky, Yasuhiro Shimada, Shuichi Hironaka, Naotoshi Sugimoto, Oleg Lipatov, Tae-You Kim,[...]. Lancet Oncol 2014
20

Phase I clinical and pharmacokinetic study of oral S-1 in patients with advanced solid tumors.
C J van Groeningen, G J Peters, J H Schornagel, H Gall, P Noordhuis, M J de Vries, S L Turner, M S Swart, H M Pinedo, A R Hanauske,[...]. J Clin Oncol 2000
130
20

Vascular endothelial growth factor a inhibition in gastric cancer.
Do Joong Park, Nicholas J Thomas, Changhwan Yoon, Sam S Yoon. Gastric Cancer 2015
45
20

Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients.
Frede Donskov, M Dror Michaelson, Igor Puzanov, Mellar P Davis, Georg A Bjarnason, Robert J Motzer, David Goldstein, Xun Lin, Darrel P Cohen, Robin Wiltshire,[...]. Br J Cancer 2015
74
20

A randomized phase II trial of S-1-oxaliplatin versus capecitabine-oxaliplatin in advanced gastric cancer.
Gun Min Kim, Hei-Cheul Jeung, Sun Young Rha, Hyo Song Kim, Inkyung Jung, Byung Ho Nam, Kyung Hee Lee, Hyun Cheol Chung. Eur J Cancer 2012
103
20

Apatinib in Combination with S-1 as First-Line Treatment in Patients with Advanced Metastatic Gastric Cancer: Results from an Open, Exploratory, Single-Arm, Phase II Trial.
Na Zhou, Chuantao Zhang, Dong Liu, Kewei Liu, Guanqun Wang, Hua Zhu, Jianli Zhang, Man Jiang, Ning Liu, Xiaochun Zhang. Oncologist 2021
5
20

Screening for gastric cancer in Asia: current evidence and practice.
Wai K Leung, Ming-shiang Wu, Yasuo Kakugawa, Jae J Kim, Khay-guan Yeoh, Khean Lee Goh, Kai-chun Wu, Deng-chyang Wu, Jose Sollano, Udom Kachintorn,[...]. Lancet Oncol 2008
616
20

The Influence of Gastric Cancer Screening on the Stage at Diagnosis and Survival: A Meta-Analysis of Comparative Studies in the Far East.
Esha Khanderia, Sheraz R Markar, Amish Acharya, Yeol Kim, Young-Woo Kim, George B Hanna. J Clin Gastroenterol 2016
29
20

Safety and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor YN968D1 in patients with advanced malignancies.
Jin Li, Xinmin Zhao, Lei Chen, Haiyi Guo, Fangfang Lv, Ka Jia, Ke Yv, Fengqing Wang, Chuan Li, Jun Qian,[...]. BMC Cancer 2010
186
20

Apatinib for chemotherapy-refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel-arm, phase II trial.
Jin Li, Shukui Qin, Jianming Xu, Weijian Guo, Jianping Xiong, Yuxian Bai, Guoping Sun, Yan Yang, Liwei Wang, Nong Xu,[...]. J Clin Oncol 2013
385
20

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial.
Charles S Fuchs, Jiri Tomasek, Cho Jae Yong, Filip Dumitru, Rodolfo Passalacqua, Chanchal Goswami, Howard Safran, Lucas Vieira Dos Santos, Giuseppe Aprile, David R Ferry,[...]. Lancet 2014
20

Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study.
Atsushi Ohtsu, Manish A Shah, Eric Van Cutsem, Sun Young Rha, Akira Sawaki, Sook Ryun Park, Ho Yeong Lim, Yasuhide Yamada, Jian Wu, Bernd Langer,[...]. J Clin Oncol 2011
819
20

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
E A Eisenhauer, P Therasse, J Bogaerts, L H Schwartz, D Sargent, R Ford, J Dancey, S Arbuck, S Gwyther, M Mooney,[...]. Eur J Cancer 2009
20

Preoperative tumor size is a critical prognostic factor for patients with Borrmann type III gastric cancer.
Kei Hosoda, Keishi Yamashita, Natsuya Katada, Hiromitsu Moriya, Hiroaki Mieno, Shinichi Sakuramoto, Shiro Kikuchi, Masahiko Watanabe. Surg Today 2015
12
20

Heterogeneity in Gastric Cancer: From Pure Morphology to Molecular Classifications.
Irene Gullo, Fátima Carneiro, Carla Oliveira, Gabriela M Almeida. Pathobiology 2018
66
20

The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer.
Feng-Hua Wang, Lin Shen, Jin Li, Zhi-Wei Zhou, Han Liang, Xiao-Tian Zhang, Lei Tang, Yan Xin, Jing Jin, Yu-Jing Zhang,[...]. Cancer Commun (Lond) 2019
236
20

Randomized, open-label, phase III study comparing irinotecan with paclitaxel in patients with advanced gastric cancer without severe peritoneal metastasis after failure of prior combination chemotherapy using fluoropyrimidine plus platinum: WJOG 4007 trial.
Shuichi Hironaka, Shinya Ueda, Hirofumi Yasui, Tomohiro Nishina, Masahiro Tsuda, Takehiko Tsumura, Naotoshi Sugimoto, Hideki Shimodaira, Shinya Tokunaga, Toshikazu Moriwaki,[...]. J Clin Oncol 2013
315
20

Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction.
Jin Li, Shukui Qin, Jianming Xu, Jianping Xiong, Changping Wu, Yuxian Bai, Wei Liu, Jiandong Tong, Yunpeng Liu, Ruihua Xu,[...]. J Clin Oncol 2016
595
20

Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment.
Hiro Sato, Noriyuki Okonogi, Takashi Nakano. Int J Clin Oncol 2020
69
20



Gastric Inflammatory Prognostic Index (GIPI) in Patients with Metastatic Gastro-Esophageal Junction/Gastric Cancer Treated with PD-1/PD-L1 Immune Checkpoint Inhibitors.
Vincenzo Formica, Cristina Morelli, Anna Patrikidou, Carmen Murias, Sabeeh Butt, Antonella Nardecchia, Jessica Lucchetti, Nicola Renzi, Kai-Keen Shiu, Mario Roselli,[...]. Target Oncol 2020
10
20

Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial.
Ken Kato, Byoung Chul Cho, Masanobu Takahashi, Morihito Okada, Chen-Yuan Lin, Keisho Chin, Shigenori Kadowaki, Myung-Ju Ahn, Yasuo Hamamoto, Yuichiro Doki,[...]. Lancet Oncol 2019
435
20

Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers.
Sarah Derks, Xiaoyun Liao, Anna M Chiaravalli, Xinsen Xu, M Constanza Camargo, Enrico Solcia, Fausto Sessa, Tania Fleitas, Gordon J Freeman, Scott J Rodig,[...]. Oncotarget 2016
182
20

Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.
J Ferlay, M Colombet, I Soerjomataram, C Mathers, D M Parkin, M Piñeros, A Znaor, F Bray. Int J Cancer 2019
20

PD-L1 Testing in Gastric Cancer by the Combined Positive Score of the 22C3 PharmDx and SP263 Assay with Clinically Relevant Cut-offs.
Yujun Park, Jiwon Koh, Hee Young Na, Yoonjin Kwak, Keun-Wook Lee, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Hye Seung Lee. Cancer Res Treat 2020
37
20

Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer.
David J Pinato, Sarah Howlett, Diego Ottaviani, Heather Urus, Aisha Patel, Takashi Mineo, Cathryn Brock, Danielle Power, Olivia Hatcher, Alison Falconer,[...]. JAMA Oncol 2019
237
20

Immunotherapy for Esophageal and Gastric Cancer.
Ronan J Kelly. Am Soc Clin Oncol Educ Book 2017
43
20

Response Rate to Chemotherapy After Immune Checkpoint Inhibition in Metastatic Urothelial Cancer.
Bernadett Szabados, Nick van Dijk, Yen Zhi Tang, Michiel S van der Heijden, Akhila Wimalasingham, Alfonso Gomez de Liano, Simon Chowdhury, Simon Hughes, Sarah Rudman, Mark Linch,[...]. Eur Urol 2018
71
20

Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer.
Seung Tae Kim, Razvan Cristescu, Adam J Bass, Kyoung-Mee Kim, Justin I Odegaard, Kyung Kim, Xiao Qiao Liu, Xinwei Sher, Hun Jung, Mijin Lee,[...]. Nat Med 2018
674
20

Molecular Classification of Gastric Cancer among Alaska Native People.
Holly A Martinson, Dominic Mallari, Christine Richter, Tsung-Teh Wu, James Tiesinga, Steven R Alberts, Matthew J Olnes. Cancers (Basel) 2020
13
20

Prognostic impacts of the combined positive score and the tumor proportion score for programmed death ligand-1 expression by double immunohistochemical staining in patients with advanced gastric cancer.
Kohei Yamashita, Masaaki Iwatsuki, Kazuto Harada, Kojiro Eto, Yukiharu Hiyoshi, Takatsugu Ishimoto, Yohei Nagai, Shiro Iwagami, Yuji Miyamoto, Naoya Yoshida,[...]. Gastric Cancer 2020
49
20

Clinical Importance of Epstein⁻Barr Virus-Associated Gastric Cancer.
Jun Nishikawa, Hisashi Iizasa, Hironori Yoshiyama, Kanami Shimokuri, Yuki Kobayashi, Sho Sasaki, Munetaka Nakamura, Hideo Yanai, Kohei Sakai, Yutaka Suehiro,[...]. Cancers (Basel) 2018
48
20


Microbiome and Gastric Cancer.
Lars Engstrand, David Y Graham. Dig Dis Sci 2020
39
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.